Recurrent Respiratory Papillomatosis: A New Horizon For An Old Disease
09-10, 10:45–12:45 (Europe/Istanbul), Phoniatrics 1 (ICC - B2 Floor - Emirgan 1)

This is a 120 minutes panel with the all aspects of recurrent respiratory papillomatosis

Moderator-Speaker Moderator-Speaker

Phoniatrician, adult and pediatric laryngologist at the Department of Otorhinolaryngology and Cervicofacial Surgery, University Medical Centre Ljubljana. Part of the educational otorhinolaryngology team at the Medical Faculty, University in Ljubljana. Special research interests: respiratory papillomatosis, pediatric tracheostomies.

This speaker also appears in:

Miss Hey is a fellowship-trained Consultant ENT Surgeon and Laryngologist at Guy’s and St Thomas’ NHS Foundation Trust in London, and also holds a visiting clinical role at King’s College Hospital. She specialises in voice, swallowing and airway disorders, with a particular interest in the care of professional and artistic voice users.

After graduating from the University of Edinburgh and completing specialist ENT training in Scotland, she undertook a Royal College of Surgeons of England-accredited Laryngology Fellowship at Guy’s Hospital. Her subspecialist interest in phonomicrosurgery, neurolaryngology and artistic voice care was further augmented through international travelling fellowships at the Massachusetts General Hospital Voice Center in Boston and the University Hospital of Rouen in France.

Miss Hey is passionate about education and is an elected member of the Faculty of Surgical Trainers at the Royal College of Surgeons of Edinburgh. She is frequently invited as faculty at national and international training events and holds several leadership roles, including council member of the British Laryngological Association, Director of the Written Examination for the European Examination Board in Laryngology, and Director of mentoring programme at Young European Laryngological Society. Within the Union of European Phoniatricians, she serves on the voice committee and is the invited host of its official podcast, The UEP Voice Box, which reaches an international audience. She is also a member of the International Recurrent Respiratory Papillomatosis Task Force and a Fellow of the Collegium Medicorum Theatri.

She has authored numerous peer-reviewed publications and book chapters, delivered invited lectures at academic meetings, and received awards for both academic and clinical excellence. She is actively involved in advancing clinical practice and patient care, including recent work on office-based laryngology published through NHS England’s Getting It Right First Time (GIRFT) initiative. Her wider work reflects a strong commitment to education, innovation and international collaboration across ENT and laryngology.

This speaker also appears in:

Dr. Vasiliki Triantafillou is an Assistant Professor in Otolaryngology-Head and Neck Surgery at the University of Pennsylvania. She completed her medical and ENT residency training at the University of Pennsylvania before pursuing dual-fellowship training in Sleep Medicine/Sleep Surgery with Dr. Raj Dedhia at the University of Pennsylvania and Laryngology at Johns Hopkins University. 

She specializes in the surgical treatment of obstructive sleep apnea and the full spectrum of laryngology disorders, with an emphasis on comprehensive airway care, awake or asleep. Her laryngology interests span from complex airway management to vocal fold lesions and paralysis.

Sara Isabel Pai, M.D., Ph.D., FACS:  Dr. Pai is a Professor of Surgery at Yale University School of Medicine. She received an A.B. from Dartmouth College with a Biochemistry and Molecular Biology major. She completed the M.D./Ph.D. program at Johns Hopkins University School of Medicine, where she completed her Ph.D. training in cancer immunology and vaccines. She completed her otolaryngology-head and neck surgery residency at Johns Hopkins Hospital.  Her research interests focus on better understanding how human papillomavirus (HPV) evades the immune system and strategies that can be applied to reactivate the host immune response against HPV-mediated tumors through vaccines and immune-modulatory drugs. She leads several investigator-initiated immunotherapy clinical trials and has a translational research laboratory that has been continuously funded by the National Institutes of Health (NIH) since 2007. She is the Director of an NCI Program Project (P01) Grant, co-chair of the NIDCR AHEAD Early Detection Cancer Research Network, and the Disease Leader for Head and Neck Cancer for the American College of Surgeons Commission on Cancer. She serves on national and international grant review panels and the advisory boards for several pharmaceutical companies.

This speaker also appears in: